Trial · NCT00550459
Results by group58
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 58
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Neurocognitive Composite Score of Speed Domains (NCS-SD; Sum of All Correct Speed Domain Z-Scores) | Placebo | 0.20 | Standard Deviation 0.61 | Z-score | |
| Change From Baseline in the Neurocognitive Composite Score of Speed Domains (NCS-SD; Sum of All Correct Speed Domain Z-Scores) | Tolvaptan (15-60 mg) | 0.39 | Standard Deviation 0.49 | Z-score | |
| Change From Baseline to Day 22 in the Individual Neurocognitive Domains Included in the Primary Endpoint: Reaction Time in Computer Tests | Placebo | 0.21 | Standard Deviation 0.86 | Z-score | |
| Change From Baseline to Day 22 in the Individual Neurocognitive Domains Included in the Primary Endpoint: Reaction Time in Computer Tests | Tolvaptan (15-60 mg) | 0.33 | Standard Deviation 0.41 | Z-score | |
| Change From Baseline in the Individual Neurocognitive Domains Included in the Primary Endpoint: Psychomotor Speed Via Morse Tapping Test | Placebo | 0.04 | Standard Deviation 0.36 | Z-score | |
| Change From Baseline in the Individual Neurocognitive Domains Included in the Primary Endpoint: Psychomotor Speed Via Morse Tapping Test | Tolvaptan (15-60 mg) | 0.31 | Standard Deviation 0.46 | Z-score | |
Change From Baseline in the Individual Neurocognitive Domains Included in the Primary Endpoint: Processing Speed of Rapid Visual Information Processing Test, Numeric Working Memory Test, and Word Recognition Test | Placebo | 0.24 | Standard Deviation 0.75 | Z-score | |
Change From Baseline in the Individual Neurocognitive Domains Included in the Primary Endpoint: Processing Speed of Rapid Visual Information Processing Test, Numeric Working Memory Test, and Word Recognition Test | Tolvaptan (15-60 mg) | 0.48 | Standard Deviation 0.91 | Z-score | |
| Change From Baseline in Overall Neurocognitive Composite Score | Placebo | 0.19 | Standard Deviation 0.39 | Z-score | |
| Change From Baseline in Overall Neurocognitive Composite Score | Tolvaptan (15-60 mg) | 0.30 | Standard Deviation 0.39 | Z-score | |
| Change From Baseline in Gait Test (Timed Get-Up-and-Go Test) | Placebo | 1.06 | Standard Deviation 5.63 | Seconds | |
| Change From Baseline in Gait Test (Timed Get-Up-and-Go Test) | Tolvaptan (15-60 mg) | -0.43 | Standard Deviation 1.54 | Seconds | |
| Change From Baseline in Postural Stability Test | Placebo | 1.3 | Standard Deviation 4.68 | Z-score | |
| Change From Baseline in Postural Stability Test | Tolvaptan (15-60 mg) | -0.35 | Standard Deviation 2.33 | Z-score | |
| Change From Baseline in Serum Sodium; ITT Population | Placebo | 2.23 | Standard Deviation 3.51 | mEq/L | |
| Change From Baseline in Serum Sodium; ITT Population | Tolvaptan (15-60 mg) | 7.04 | Standard Deviation 3.39 | mEq/L | |
| Number of Patients With Vital Sign Abnormalities: Blood Pressure | Placebo | 2 | participants | ||
| Number of Patients With Vital Sign Abnormalities: Blood Pressure | Tolvaptan (15-60 mg) | 0 | participants | ||
| Number of Patients With Vital Sign Abnormalities: Pulse Rate | Placebo | 0 | participants | ||
| Number of Patients With Vital Sign Abnormalities: Pulse Rate | Tolvaptan (15-60 mg) | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00550459/results